Outlook Therapeutics
OTLK
#8305
Rank
โ‚น12.61 B
Marketcap
โ‚น533.25
Share price
-5.25%
Change (1 day)
-28.09%
Change (1 year)

Outlook Therapeutics (OTLK) - P/B ratio

P/B ratio as of November 2024 : -1.76

According to Outlook Therapeutics 's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Outlook Therapeutics - P/B ratio (from 2016 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31-4.21-127.18%
2022-12-3115.5148.1%
2021-12-316.25-139.58%
2020-12-31-15.81668.62%
2019-12-31-0.8925-54.97%
2018-12-31-1.98-52.84%
2017-12-31-4.2029.27%
2016-12-31-3.25
2015-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
5.42-407.86% Jersey
-3.32 88.65%๐Ÿ‡บ๐Ÿ‡ธ USA
0.9590-154.45%๐Ÿ‡บ๐Ÿ‡ธ USA
4.74-368.90%๐Ÿ‡ฌ๐Ÿ‡ง UK